Presentations by Peter Sampson on M4ND and M4K Pharma

Presentations by Peter Sampson (VP Drug Discovery and Development, Agora Open Science Trust) on M4ND and M4K Pharma. Given at the 2025 Conscience Symposium on Open Drug Discovery. Small Molecule PRMT6 Inhibitors for the Treatment of Spinal Bulbar Muscular Atrophy (SBMA) Pre-Clinical Development of an ALK2 Inhibitor for the Treatment of DIPG

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-08
DOI
https://doi.org/10.5281/zenodo.15361121
Primary Topic
Cancer-related gene regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Presentations by Peter Sampson on M4ND and M4K Pharma

Zenodo (CERN European Organization for Nuclear Research)
Cancer-related gene regulation
article

Presentations by Peter Sampson on M4ND and M4K Pharma

article en

Abstract

Presentations by Peter Sampson (VP Drug Discovery and Development, Agora Open Science Trust) on M4ND and M4K Pharma. Given at the 2025 Conscience Symposium on Open Drug Discovery. Small Molecule PRMT6 Inhibitors for the Treatment of Spinal Bulbar Muscular Atrophy (SBMA) Pre-Clinical Development of an ALK2 Inhibitor for the Treatment of DIPG

Zenodo (CERN European Organization for Nuclear Research)
Open Society (CZ), Intrinsic LifeSciences (United States) (US)
Partnerships for the goals
Openalex Percentile: Top 53%
Cancer-related gene regulation
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Presentations by Peter Sampson on M4ND and M4K Pharma · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS